Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
AbCellera is an antibody discovery and development company that develops antibody therapeutics to improve patient outcomes.
Remedium Bio is a gene therapy company focused on the development of highly innovative treatments for a broad range of diseases.
Seraxis is a privately owned biotechnology company.
Stylus Medicine is on a quest to create disease-treating agents for the next generation based on the groundbreaking work of its founders.
Incyclix Bio develops small molecule inhibitors of CDKs for the treatment of advanced and resistant cancers.
Iterative Health develops technology that can benefit patients anywhere, regardless of socioeconomic or geographic barriers.
Grove Biopharma is a biotechnology company offering a materials science solution to peptide therapeutic challenges.
Trans Solutions Research and Resource Center empowers transgender and gender communities.
Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.
Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases
Flare Therapeutics is a biotech startup that creates precision therapies for cancer and other disorders by targeting transcription factors.
Crossbow Therapeutics is a biotech company that develops targeted therapies to address cancer antigens.
Maxion Therapeutics helps in learning transformative therapies.
Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.
Zephyr AI is a healthcare technology company that reshapes traditional approaches to drug discovery and precision medicine.
IgGenix is a biotechnology company.
Blacksmith Medicines developing medicines targeting metal-dependent enzymes found in human physiology.
Arkuda Therapeutics is a pharmaceutical company.
Trogenix is a biotech company that develops precision cancer treatments that selectively target diseased cell states and behaviour.
Dualitas Therapeutics is leading the way in bispecific antibody treatments for inflammatory and immunological (I&I) disorders
Syndeio Biosciences is a newly launched biotech company pioneering precision neurotherapeutics.
Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases.
Eli Lilly has invested in 163 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Eli Lilly's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 21 different industry categories.
Among tracked funding rounds, AbCellera received $515.8M in a Grant round. Eli Lilly's total known invested capital is $12.0B.
Eli Lilly's average investment size is $90.8M across its portfolio of 163 companies.
Recent Eli Lilly portfolio additions include LTZ Therapeutics, Cabaletta Bio, AbCellera, Remedium Bio, Seraxis. These companies were founded in 2020 or later.